ERBB2 and gastric cancer: To determine the association of HER2 overexpression and/or amplification with EMT in gastric cancer at tissue levels, we examined HER2 protein expression by immunohistochemistry (IHC) and DNA amplification by fluorescence in situ hybridization (FISH) in a cohort of 382 gastric cancer samples with a 5-year follow-up.